Factors associated with COVID-19 vaccine hesitancy in Senegal: a mixed study

Summary Introduction The most effective way to control the COVID-19 pandemic in the long term is through vaccination. Two of the important components that can hinder it are vaccine hesitancy and vaccine refusal. This study, conducted before the arrival of the vaccines in Senegal, aims to assess and identify factors associated with hesitancy to the COVID-19 vaccine.Methods This study was an explanatory, sequential, mixed-methods design. We collected quantitative data from December 24, 2020, to January 16, 2021, and qualitative data from February 19 to March 30, 2021. We conducted a marginal quota sampling nationwide. We used a structured questionnaire to collect data for the quantitative phase and an interview guide with a telephone interview for the qualitative phase. We performed descriptive, bivariate, and multivariate analyses with R software version 4.0.5 for the quantitative phase; and performed manual content analyses for the qualitative phase.Results We surveyed 607 people for the quantitative phase, and interviewed 30 people for the qualitative phase. Individuals who hesitated or refused to be vaccinated represented 12.9% and 32.8%, respectively. Vaccine hesitancy was related to gender, living in large cities, having a poor attitude towards the vaccine, thinking that the vaccine would not help protect them from the virus, being influenced by people important to them, and lacking information from health professionals. Vaccine refusal was related to living in large cities, having a poor attitude towards the vaccine, thinking that the vaccine would not help protect them from the virus, thinking that the vaccine could endanger their health, trusting opinions of people who were important to them, and lacking information from health professionals.Conclusion The results of the study show that the factors associated with hesitancy and refusal to be vaccinated against COVID-19 are diverse and complex. Reducing them will help to ensure better vaccination coverage if the current challenges of vaccine accessibility are addressed. Therefore, governments and health authorities should intensify their efforts to promote vaccine confidence and reduce misinformation..

Medienart:	Preprint

Erscheinungsjahr:	2021
Erschienen:	2021

Enthalten in:	bioRxiv.org - (2021) vom: 24. Dez. Zur Gesamtaufnahme - year:2021

Sprache:	Englisch

Beteiligte Personen:	Ba, Mouhamadou Faly [VerfasserIn] Faye, Adama [VerfasserIn] Kane, Babacar [VerfasserIn] Diallo, Amadou Ibra [VerfasserIn] Junot, Amandine [VerfasserIn] Gaye, Ibrahima [VerfasserIn] Bonnet, Emmanuel [VerfasserIn] Ridde, Valéry [VerfasserIn]

Links:	Volltext [kostenfrei]

doi:	10.1101/2021.12.20.21267724

funding:
Förderinstitution / Projekttitel:

PPN (Katalog-ID):	XBI033278202